PASSION Trial's Premature End Highlights Tadalafil's Ineffectiveness and Possible Risks for HFpEF Patients Medha Baranwal5 Aug 2024 9:00 AM ISTGermany: The PASSION trial, which was halted early due to issues with the study medication supply, does not endorse tadalafil use for patients with...
New HFpEF-ABA Score Simplifies Screening for Undiagnosed HFpEF with Basic Patient Data: Study Medha Baranwal5 Aug 2024 9:00 AM ISTUSA: A recent advancement in cardiology promises to enhance the diagnosis and management of heart failure with preserved ejection fraction (HFpEF)...
Dapagliflozin Enhances Right Ventricular Function in Heart Failure Patients, shows study Medha Baranwal27 July 2024 9:30 AM ISTUSA: Dapagliflozin enhances right ventricular pulsatile afterload and myocardial performance during exercise, which correlates with a reduction in...
New study advocates for initiation of statins in primary prevention for heart failure with preserved ejection fraction Medha Baranwal23 May 2024 8:00 PM ISTUSA: In a paradigm-shifting revelation, a recent study has advocated for the initiation of statins as a primary prevention measure for individuals at...
Patients with thicker epicardial adipose tissue and HFpEF at higher risk of coronary artery disease: Study Medha Baranwal29 April 2024 10:00 AM ISTChina: A recent study has revealed that epicardial adipose tissue (EAT) is correlated with coronary artery disease (CAD) in patients with heart...
Atrial Shunt Devices may Redefine Heart Failure Management: JAMA Medha Baranwal19 April 2024 10:00 AM ISTUSA: Heart failure with preserved ejection fraction (HFpEF) presents a complex clinical challenge, with limited treatment options compared to heart...
Elevated stress hyperglycemia ratio independently predicts poor survival in patients with heart failure: Study Medha Baranwal22 Feb 2024 7:30 PM ISTChina: A recent study has identified an independent association between elevated stress hyperglycemia ratio (SHR) and an increased risk for composite...
Beta-blocker cessation benefits HFpEF patients with chronotropic incompetence and smaller end-systolic left ventricular volume: JAMA Medha Baranwal12 Feb 2024 11:15 AM ISTSpain: In patients with heart failure with preserved ejection fraction (HFpEF) and chronotropic incompetence, beta-blocker cessation may be...
Patients of HFpEF and anaemia may have exercise intolerance and lower exercise capacity Aditi20 Jan 2024 2:15 AM ISTHeart failure with preserved ejection fraction (HFpEF) is becoming more common. This condition is primarily manifested as exercise intolerance....
Insulin resistance associated with cardiovascular pathology that contributes to HF Medha Baranwal16 Dec 2023 11:00 AM ISTUSA: A recent study published in the Journal of Cardiology has revealed an association of insulin resistance with subclinical myocardial dysfunction...
Semaglutide treatment benefits patients with heart failure and obesity: STEP-HFpEF trial Dr. Kamal Kant Kohli17 Nov 2023 10:45 AM ISTUSA: Obese patients with heart failure with preserved ejection fraction (HFpEF) treated with 2.4 mg semaglutide showed larger reductions in physical...
Semaglutide effective in improving symptoms in obese heart failure patients, NEJM study dr. Abhimanyu Uppal28 Sept 2023 10:45 AM ISTSemaglutide, a glucagon-like peptide 1 (GLP-1) agonist is the latest entry in the arena of medications combating heart failure with preserved ejection...
